These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35075731)

  • 1. Health technology assessment for gene therapies in haemophilia.
    O'Hara J; Neumann PJ;
    Haemophilia; 2022 Mar; 28 Suppl 2():19-26. PubMed ID: 35075731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative payment models for durable and potentially curative therapies: The case of gene therapy for haemophilia A.
    Goodman C; Berntorp E; Wong O;
    Haemophilia; 2022 Mar; 28 Suppl 2():27-34. PubMed ID: 35060645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary application of a haemophilia value framework to emerging therapies in haemophilia.
    Skinner MW; Dolan G; Eichler H; O'Mahony B;
    Haemophilia; 2022 Mar; 28 Suppl 2():9-18. PubMed ID: 35318780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the world ready for gene therapy?
    Garrison LP; Kleinermans D
    Haemophilia; 2022 Mar; 28 Suppl 2():5-8. PubMed ID: 35318781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies.
    Spadarella G; Di Minno A; Brunetti-Pierri N; Mahlangu J; Di Minno G
    Blood Rev; 2021 Mar; 46():100737. PubMed ID: 32739122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment and haemophilia.
    Farrugia A; O'Mahony B; Cassar J
    Haemophilia; 2012 Mar; 18(2):152-7. PubMed ID: 22335450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations.
    Garrison LP; Pezalla E; Towse A; Yang H; Faust E; Wu EQ; Li N; Sawyer EK; Recht M
    Value Health; 2021 Nov; 24(11):1628-1633. PubMed ID: 34711363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Falls prevention for the elderly.
    Balzer K; Bremer M; Schramm S; Lühmann D; Raspe H
    GMS Health Technol Assess; 2012; 8():Doc01. PubMed ID: 22536299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a "Shared Savings" Approach to Cost Offsets.
    Chapman RH; Kumar VM; Whittington MD; Pearson SD
    Value Health; 2021 Jun; 24(6):839-845. PubMed ID: 34119082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-, under- and misuse of pain treatment in Germany.
    Dietl M; Korczak D
    GMS Health Technol Assess; 2011 Apr; 7():Doc03. PubMed ID: 21522485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies.
    Coyle D; Durand-Zaleski I; Farrington J; Garrison L; Graf von der Schulenburg JM; Greiner W; Longworth L; Meunier A; Moutié AS; Palmer S; Pemberton-Whiteley Z; Ratcliffe M; Shen J; Sproule D; Zhao K; Shah K
    Eur J Health Econ; 2020 Dec; 21(9):1421-1437. PubMed ID: 32794011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.